Cost–Utility and Budget Impact Analysis for Stopping the Inappropriate Use of Proton Pump Inhibitors After Cessation of NSAID or Low-Dose Acetylsalicylic Acid Treatment

BACKGROUND: In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding...

Descripción completa

Detalles Bibliográficos
Autores principales: Chau, Sek Hung, Sluiter, Reinier Luuk, Hugtenburg, Jacqueline Geertruida, Wensing, Michel, Kievit, Wietske, Teichert, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965335/
https://www.ncbi.nlm.nih.gov/pubmed/31560115
http://dx.doi.org/10.1007/s40266-019-00713-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965335/
https://www.ncbi.nlm.nih.gov/pubmed/31560115
http://dx.doi.org/10.1007/s40266-019-00713-5

Ejemplares similares